Lovaza(R) : potent, pure, and proven?
Metadata[+] Show full item record
Lovaza (omega-3-acid ethyl esters), formerly Omacor(R), is a combination prescription formulation of 465 mg eicosapentaenoic acid (EPA) and 375 mg docosahexaenoic acid (DHA) approved in the United States for the treatment of patients with hypertriglyceridemia (greater than or equal to 500 mg/dL). One study has shown efficacy with Lovaza for secondary prevention of coronary heart disease (CHD) events. Over-the-counter (OTC) omega-3 products have been studied more widely and have demonstrated efficacy in both primary and secondary prevention.
Evidence-based practice 11, no. 03 (2008): 10-11